 |
PDBsum entry 5n4w
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
671 a.a.
|
 |
|
|
|
|
|
|
|
37 a.a.
|
 |
|
|
|
|
|
|
|
86 a.a.
|
 |
|
|
|
|
|
|
|
82 a.a.
|
 |
|
|
|
|
|
|
|
91 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Ligase
|
 |
|
Title:
|
 |
Crystal structure of the cul2-rbx1-elobc-vhl ubiquitin ligase complex
|
|
Structure:
|
 |
Cullin-2. Chain: a. Synonym: cul-2. Engineered: yes. Von hippel-lindau disease tumor suppressor. Chain: v. Synonym: protein g7,pvhl. Engineered: yes. E3 ubiquitin-protein ligase rbx1.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cul2. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf21. Gene: vhl. Expressed in: escherichia coli.
|
|
Resolution:
|
 |
|
3.90Å
|
R-factor:
|
0.304
|
R-free:
|
0.346
|
|
|
Authors:
|
 |
T.A.F.Cardote,M.S.Gadd,A.Ciulli
|
|
Key ref:
|
 |
T.A.F.Cardote
et al.
(2017).
Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
Structure,
25,
901.
PubMed id:
|
 |
|
Date:
|
 |
|
11-Feb-17
|
Release date:
|
07-Jun-17
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q13617
(CUL2_HUMAN) -
Cullin-2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
745 a.a.
671 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P40337
(VHL_HUMAN) -
von Hippel-Lindau disease tumor suppressor from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
213 a.a.
37 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P62877
(RBX1_HUMAN) -
E3 ubiquitin-protein ligase RBX1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
108 a.a.
86 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, V, B, C:
E.C.?
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain R:
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chain R:
E.C.2.3.2.32
- cullin-RING-type E3 NEDD8 transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-[NEDD8-protein]-yl-[E2 NEDD8-conjugating enzyme]-L-cysteine + [cullin]- L-lysine = [E2 NEDD8-conjugating enzyme]-L-cysteine + N6-[NEDD8- protein]-yl-[cullin]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Structure
25:901
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
|
|
T.A.F.Cardote,
M.S.Gadd,
A.Ciulli.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cullin RING E3 ubiquitin ligases (CRLs) function in the ubiquitin proteasome
system to catalyze the transfer of ubiquitin from E2 conjugating enzymes to
specific substrate proteins. CRLs are large dynamic complexes and attractive
drug targets for the development of small-molecule inhibitors and chemical
inducers of protein degradation. The atomic details of whole CRL assembly and
interactions that dictate subunit specificity remain elusive. Here we present
the crystal structure of a pentameric CRL2VHLcomplex, composed of
Cul2, Rbx1, Elongin B, Elongin C, and pVHL. The structure traps a closed state
of full-length Cul2 and a new pose of Rbx1 in a trajectory from closed to open
conformation. We characterize hotspots and binding thermodynamics at the
interface between Cul2 and pVHL-EloBC and identify mutations that contribute
toward a selectivity switch for Cul2 versus Cul5 recognition. Our findings
provide structural and biophysical insights into the whole Cul2 complex that
could aid future drug targeting.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |